• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Will non-steroid approaches to the treatment of inflammation replace our need for glucocorticoids?

作者信息

Whelan Clifford J

机构信息

Department of Biosciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire, AL 10 9AB, UK.

出版信息

Curr Opin Investig Drugs. 2003 May;4(5):536-43.

PMID:12833646
Abstract

Glucocorticoids are widely used as anti-inflammatory agents, however, their use is limited by side effects. A long-term goal of pharmaceutical research has been the development of an agent that will mimic the anti-inflammatory actions of glucocorticoids without the undesirable side effects. This article reviews the diverse pharmacological approaches used to identify likely glucocorticoid substitutes and compares successful and unsuccessful approaches. All anti-inflammatory drugs that demonstrate clinical utility share an ability to modulate lymphocyte function. Given that glucocorticoids are also potent inhibitors of lymphocyte function, this property may be essential for clinically useful anti-inflammatory activity.

摘要

相似文献

1
Will non-steroid approaches to the treatment of inflammation replace our need for glucocorticoids?
Curr Opin Investig Drugs. 2003 May;4(5):536-43.
2
Advances in anti-inflammatory therapy.
Br Vet J. 1994 Mar-Apr;150(2):115-34. doi: 10.1016/S0007-1935(05)80221-0.
3
The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.糖皮质激素在炎症中作用的分子复杂性——一场四环马戏。
Curr Opin Pharmacol. 2004 Dec;4(6):629-36. doi: 10.1016/j.coph.2004.06.009.
4
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
5
Inflammatory resolution: new opportunities for drug discovery.炎症消退:药物研发的新机遇。
Nat Rev Drug Discov. 2004 May;3(5):401-16. doi: 10.1038/nrd1383.
6
Drug insight: selective agonists and antagonists of the glucocorticoid receptor.药物洞察:糖皮质激素受体的选择性激动剂和拮抗剂
Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):91-101. doi: 10.1038/ncpendmet0745.
7
Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.选择性糖皮质激素受体激动剂(SEGRAs):具有改善治疗指数的新型配体。
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):109-17. doi: 10.1016/j.mce.2007.05.014. Epub 2007 May 31.
8
Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway.噻唑烷二酮类药物抗炎作用的机制:与糖皮质激素途径的关系。
Mol Pharmacol. 2005 May;67(5):1620-8. doi: 10.1124/mol.104.004895. Epub 2005 Jan 31.
9
Anti-inflammatory effects of butadiene Diels-Alder adducts to some 1-dehydroglucocorticoids in rats.丁二烯狄尔斯-阿尔德加合物对大鼠某些1-脱氢糖皮质激素的抗炎作用。
Eur J Pharm Sci. 2004 Apr;21(5):575-9. doi: 10.1016/j.ejps.2003.12.008.
10
CF-Emerging therapies: Modulation inflammation.囊性纤维化——新兴疗法:调节炎症
Paediatr Respir Rev. 2006;7 Suppl 1:S170-4. doi: 10.1016/j.prrv.2006.04.212. Epub 2006 Jun 5.

引用本文的文献

1
The Journal of Inflammation.《炎症杂志》
J Inflamm (Lond). 2004 Sep 27;1(1):1. doi: 10.1186/1476-9255-1-1.